Minia University
Minya, 61611, Egypt
NCT Number: NCT06884774
This study aims to compare the lateral internal sphincterotomy versus no lateral internal sphincterotomy during hemorrhoidectomy in the management of patients with hemorrhoids.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Minya, 61611, Egypt
Hemorrhoidectomy is associated with postoperative pain, and no single surgical technique has been proven to reduce the pain significantly.
However, there are many drawbacks to such techniques, such as postoperative pain and constipation. The cause of this postoperative pain is multifactorial. Spasm of the internal anal sphincter (IAS) is one of the factors which is exposed and impinged after EH. Therefore, Lateral internal sphincterotomy (LIS) is a widely used adjunct treatment after EH, which can abolish spasms of the IAS and subsequently relieve postoperative pain.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients undergoing Hemorrhoidectomy with lateral internal sphincterotomy.
Patients undergoing Hemorrhoidectomy without lateral internal sphincterotomy.
Time frame: 4 weeks postoperatively
The pain was measured by visual analog scoring (VAS) described as : 0-no pain, at score 1 to 3- mild pain, score 4 to 6-moderate pain, at score 7 to 10- severe pain. Post-operative pain was observed on subsequent visits after 48 hours, one week and 4 weeks postoperatively.
Time frame: 48 hours postoperatively.
Incontinence was assessed by Wexner's incontinence score for solid, liquid, and gas until 48 hours postoperatively
Minia University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06860100
Cardiovascular Diseases, Digestive System Diseases
Van, Tuşba, Turkey (Türkiye)
View Trial DetailsNCT05089500
Cardiovascular Diseases, Digestive System Diseases
Wuhan, Hubei, China
View Trial DetailsNCT01881282
Cardiovascular Diseases, Digestive System Diseases
Beijing, China
View Trial DetailsNCT05519189
Cardiovascular Diseases, Digestive System Diseases
La Roche-sur-Yon, France
View Trial Details